The use of machine learning to perform blood cell counts for diagnosis of disease instead of expensive and often less accurate cell analyzer machines has nevertheless been very labor-intensive as it ...
Biotech startup Labro Inc. has raised $1.5 million in seed funding to accelerate pilot deployments of its flagship automated cell-counting system, and expand its offerings for clinical and academic ...
The use of machine learning to perform blood cell counts for diagnosis of disease instead of expensive and often less accurate cell analyzer machines has nevertheless been very labor-intensive as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results